The Impact of Point-of-Care Ultrasound
1 other identifier
observational
112
0 countries
N/A
Brief Summary
Point-of-care ultrasound (POCUS) has been found to be useful for aiding in the prediction of fluid responsiveness. It is unknown if trainees can effectively utilize this tool to improve their assessment of fluid responsiveness. In this prospective, observational study, pulmonary and critical care fellows are asked to make 2 assessments of fluid responsiveness in adults with shock: (1) based on clinical exam alone (Clinical) and (2) after performing a POCUS (Clinical + US). The accuracy of their pre- and post-ultrasound assessments are compared using a bioreactance monitor and passive leg raise test as the gold standard of fluid responsiveness in this study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2014
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 21, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 17, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
April 17, 2015
CompletedFirst Submitted
Initial submission to the registry
September 6, 2017
CompletedFirst Posted
Study publicly available on registry
September 8, 2017
CompletedSeptember 8, 2017
September 1, 2017
9 months
September 6, 2017
September 6, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Fluid responsiveness
Increase of stroke volume index greater than 10% following passive leg raise testing
Immediately subsequent to performance of a point-of-care ultrasound exam
Study Arms (1)
Shock
Interventions
Point-of-care ultrasound examination by pulmonary and critical care fellow
Eligibility Criteria
* Could undergo both a POCUS and bioreactance assessment within 6 hours of admission from the emergency department or transfer from a medical floor. * Shock was defined as either systolic blood pressure less than 90 mmHg or 40 mmHg below baseline, necessity for vasopressors to maintain mean arterial pressure greater than 65 mmHg, or any evidence of acute organ hypoperfusion that was evident at the time of study enrollment as judged by the treating physician. * The patient needed to be in shock at the time of POCUS and bioreactance testing at time of enrollment in order to be included.
You may qualify if:
- Adults age 18 or older admitted to the MICU with a diagnosis of shock while a fellow was on duty.
You may not qualify if:
- None
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Montefiore Medical Centerlead
- Beth Israel Medical Centercollaborator
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Medicine
Study Record Dates
First Submitted
September 6, 2017
First Posted
September 8, 2017
Study Start
July 21, 2014
Primary Completion
April 17, 2015
Study Completion
April 17, 2015
Last Updated
September 8, 2017
Record last verified: 2017-09